Eli Total Revenue from 2010 to 2024

LLY Stock  USD 748.01  1.91  0.25%   
Eli Lilly Total Revenue yearly trend continues to be fairly stable with very little volatility. Total Revenue is likely to outpace its year average in 2024. Total Revenue is the total amount of income generated by the sale of goods or services related to Eli Lilly's primary operations. View All Fundamentals
 
Total Revenue  
First Reported
1985-09-30
Previous Quarter
11.3 B
Current Value
11.4 B
Quarterly Volatility
2.3 B
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Eli Lilly financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eli Lilly's main balance sheet or income statement drivers, such as Depreciation And Amortization of 941.5 M, Interest Expense of 510.2 M or Total Revenue of 35.8 B, as well as many indicators such as Price To Sales Ratio of 16.15, Dividend Yield of 0.0074 or PTB Ratio of 51.15. Eli financial statements analysis is a perfect complement when working with Eli Lilly Valuation or Volatility modules.
  
Check out the analysis of Eli Lilly Correlation against competitors.

Latest Eli Lilly's Total Revenue Growth Pattern

Below is the plot of the Total Revenue of Eli Lilly and over the last few years. Total revenue comprises all receipts Eli Lilly generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. Eli Lilly's Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eli Lilly's overall financial position and show how it may be relating to other accounts over time.
Total Revenue10 Years Trend
Slightly volatile
   Total Revenue   
       Timeline  

Eli Total Revenue Regression Statistics

Arithmetic Mean23,473,873,667
Geometric Mean21,420,853,822
Coefficient Of Variation31.47
Mean Deviation4,639,635,067
Median22,871,300,000
Standard Deviation7,387,471,228
Sample Variance54574731.1T
Range32.6B
R-Value0.77
Mean Square Error23716132.2T
R-Squared0.60
Significance0.0007
Slope1,275,786,196
Total Sum of Squares764046236.1T

Eli Total Revenue History

202435.8 B
202334.1 B
202228.5 B
202128.3 B
202024.5 B
201922.3 B
201821.5 B

About Eli Lilly Financial Statements

Eli Lilly investors use historical fundamental indicators, such as Eli Lilly's Total Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Eli Lilly. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue34.1 B35.8 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Eli Stock Analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.